Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages

Journal article

Schulthess J. et al, (2019), Immunity

CD161 defines a functionally distinct subset of pro-inflammatory natural killer cells

Journal article

Kurioka A. et al, (2018), Frontiers in Immunology, 9

Innate Lymphoid Cells in Intestinal Inflammation.

Journal article

Geremia A. and Arancibia-Cárcamo CV., (2017), Frontiers in immunology, 8, 1296 - 1296

The role of minor histocompatibility alloantigens in penetrating keratoplasty.

Journal article

Arancibia C. et al, (2017), Dev Ophthalmol

RORγt inhibitors suppress T(H)17 responses in inflammatory arthritis and inflammatory bowel disease.

Journal article

de Wit J. et al, (2016), J Allergy Clin Immunol, 137, 960 - 963

Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity.

Journal article

Paterson AM. et al, (2015), J Exp Med, 212, 1603 - 1621


Journal article

De Wit J. et al, (2014), CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 32, 811 - 811

Expression and regulation of the TGF-beta-activating integrin alpha(v)beta(8) on human dendritic cells

Conference paper

Fenton TM. et al, (2013), IMMUNOLOGY, 140, 147 - 148

Co‐Administration of Co‐Stimulatory Moieties


Latchman YE. and Arancibia CV., (2012), Vaccinology Principles and Practice, 375 - 392

IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease.

Journal article

Geremia A. et al, (2011), J Exp Med, 208, 1127 - 1133

Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis.

Journal article

Izcue A. et al, (2008), Immunity, 28, 559 - 570

Role of ICOS in regulating mucosal tolerance.

Conference paper

Arancibia CV. and Sharpe AH., (2005), CLINICAL IMMUNOLOGY, 115, S230 - S230

A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites.

Journal article

Arancibia-Cárcamo CV. et al, (2004), Eur J Immunol, 34, 471 - 480

Load More